Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleNew Research, Sensory and Motor Systems

Synaptic Inhibition in Avian Interaural Level Difference Sound Localizing Neurons

Rebecca J. Curry and Yong Lu
eNeuro 9 December 2016, 3 (6) ENEURO.0309-16.2016; DOI: https://doi.org/10.1523/ENEURO.0309-16.2016
Rebecca J. Curry
1Department of Anatomy and Neurobiology, College of Medicine, Northeast Ohio Medical University, Rootstown, Ohio 44272
2School of Biomedical Sciences, Kent State University, Kent, Ohio 44240
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rebecca J. Curry
Yong Lu
1Department of Anatomy and Neurobiology, College of Medicine, Northeast Ohio Medical University, Rootstown, Ohio 44272
2School of Biomedical Sciences, Kent State University, Kent, Ohio 44240
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Synaptic inhibition in the LLDp is largely GABAergic. A, The LLDp (arrow) is located laterally within a 300-μm-thick coronal brainstem slice with ∼4 mm between the two LLDps. B, The LLDp is readily identifiable as a heavily myelinated nucleus medial and slightly ventral to the semilunar nucleus (SLu) in fresh tissue slices. C, Schematic of the experimental setup highlighting ipsilateral recording site (blue, left), and medial electrical stimulation of fibers projecting from the contralateral LLDp. D, Bath application of gabazine (10 μm), a GABAA receptor antagonist, abolished the eIPSC, whereas the eIPSC amplitude was not affected by strychnine (1 μm), a glycine receptor antagonist. E, Averaged traces of the eIPSC during control (black), strychnine (1 μm, blue), gabazine (10 μm, red), and wash (gray). F, In the majority of cells, eIPSCs were abolished by gabazine alone (n = 10), although occasionally an additional weak strychnine component was observed (n = 3). G–I, Population data of eIPSC amplitude, 20–80% rise time, and decay time constant (tau) for GABAergic eIPSCs (n = 10). For this and subsequent figures, mean ± SEM values are shown. d, dorsal; m, medial; ctrl, Control; stim, stimulation.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    LLDp neurons have functional GABAA and glycine receptors. A, Schematic of the experimental setup highlighting direct puff application of receptor agonists to the recorded cell. B, C, In all neurons recorded, puff application of muscimol (GABAA receptor agonist, 10 μm, red; B) and glycine (glycine receptor agonist, 500 μm, blue; C) evoked IPSCs, which were blocked by their respective antagonists, gabazine (10 μm) and strychnine (1 μm). D, Amplitude of IPSCs did not significantly differ among puff application of muscimol (n = 7), glycine (n = 11), or a mixture of muscimol and glycine (n = 5), suggesting that GABA and glycine may interfere with each other. E, F, sIPSCs (top, black) were pharmacologically isolated into GABAergic sIPSCs (E, red) or glycinergic sIPSCs (F, blue) with bath application of strychnine (1 μm) or gabazine (10 μm), respectively. Averaged sIPSCs (bottom, thick lines) show distinct decay kinetics between GABAergic and glycinergic sIPSCs. G–I, Population data of sIPSC amplitude, 20–80% rise time, and decay tau. Population data for decay tau (I) shows significant difference between GABAergic (n = 3) and glycinergic sIPSCs (n = 3; p = 0.008, ANOVA with post hoc Fisher’s exact test). For this and subsequent figures: *p < 0.05, **p < 0.01, and ***p < 0.001. ctrl, Control; gly, glycine.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    IPSCs can be evoked electrically or chemically from activation of the contralateral LLDp. A, Schematic of the experimental setup for electrical activation of contralateral LLDp, highlighting ipsilateral recording site (blue), and the following two stimulating locations: medial (left) and in the contralateral LLDp (right). B, C, Averaged eIPSCs from medial LLDp (B) and contralateral LLDp (C) stimulation in the same neuron. Note the larger amplitude and shorter latency in the medial eIPSC. Bath application of gabazine (10 μm, red) completely abolished both medial and contralateral eIPSCs. D–G, The contralateral eIPSC population data for amplitude, latency, 20–80% rise time, and decay tau (n = 10). H, Schematic of experimental setup for chemical activation of contralateral LLDp, highlighting ipsilateral recording site (blue), and direct puff application of glutamate in the contralateral LLDp (green, right). I, For a single neuron, puff application of glutamate (150 μm, 5–10 psi, 10 s) on the contralateral LLDp produced PSCs that were abolished by bath application of gabazine (10 μm) and strychnine (1 μm). Enlarged views of PSCs are shown to the right during puff glutamate (top, green), puff glutamate with inhibition blockers (middle, purple), and wash (bottom, gray). J, Overlay of individual PSCs (thin lines) and their average (thick line) during control (left, black) and during glutamate puff application in the following conditions: ACSF (top), inhibition blockers (middle), and wash (bottom). K, Overlay of averaged PSCs. L, Cumulative probability of PSC amplitude shows that PSCs during puff glutamate (green) have larger amplitudes compared with control (black) and puff glutamate with inhibition blockers (purple) conditions in a sample cell. M, Distribution of PSC amplitude shows a bimodal distribution of PSCs during glutamate application (green), with a population of events >100 pA, which is not seen in the control or during the inhibition blockers condition. N, Cumulative probability of the IEI between PSCs shows a decrease in IEI during puff glutamate (green) and wash (gray) compared with control (black), and puff glutamate compared with inhibition blockers (purple). O–Q, Sample traces from three individual neurons with varying degrees of responsiveness to contralateral glutamate puff (green bar). ctrl, Control.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Intrinsic regulation of the Erev for Cl− channels in LLDp neurons. A, eIPSCs from a sample neuron were inward initially (black) and shifted polarity (blue) during whole-cell recording. B, The eIPSC amplitudes are plotted over time showing that the shift occurred at about 8 min after whole-cell recording began. C, Population data of eIPSC amplitude over time (n = 16). eIPSCs were largely observed as inward currents initially, but in many cells the current became outward over time during whole-cell recordings. The shift in polarity generally occurred within 20 min. D, After the eIPSC became outward, bath application of furosemide (500 μm), a KCC2 antagonist, returned the eIPSC to an inward current. Inset, eIPSC traces correspond to the following conditions: control (a, 1 min), after the polarity shift (b, 10 min), and during furosemide application (c, 28 min). E, The Erev during control (left), after the polarity shift (middle, +10 min), and during furosemide application (right) was determined by stepping the holding potential from −113 up to −33 mV (increment of 20 mV) during whole-cell recordings. The dashed lines approximately indicate the Erev. F, Average Erev was 11.8 mV more hyperpolarized than control after the polarity shift (n = 5, blue) and returned to near control levels during furosemide application (n = 5, orange). For the four of five cells that were affected by furosemide, the Erev after the polarity shift was significantly different from control and furosemide application (p = 0.036, RM-ANOVA with post hoc Bonferroni test). G, Schematic of experimental setup for gramicidin-perforated patch recording, highlighting the gramicidin-containing internal solution (with high Cl− concentration, 145 mm) and native Cl− concentration within the LLDp neuron. H, I, With gramicidin-perforated patch recording, sIPSCs were recorded under different membrane holding potentials (−125 up to −45 mV, increment of 20 mV) to determine Erev. Individual and averaged sIPSCs are shown to the right. J, The calculated Erev for sIPSCs (n = 5) was 21.6 mV more negative than the average RMP (p = 0.022, paired t test). K, The calculated Cl− concentration was relatively low (n = 5). ctrl, Control.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Contralateral synaptic inhibition reduces firing in LLDp neurons. A, Schematic of the experimental setup, highlighting the electrical stimulation of the contralateral LLDp (right) during whole-cell current-clamp recordings. B, Schematic of the current-clamp protocol used to evaluate the effects of contralateral inhibition on spiking activity. A depolarizing current step (200 ms, 100 pA above threshold) was injected into the cell body to evoke APs. This was followed by or overlapped with a contralateral electrical stimulation (100 Hz, 200 ms, 20 pulses) for the baseline condition and the experimental condition, respectively. E+I, With overlapping excitation and inhibition. The intensity of the electrical stimulation was increased in a stepwise fashion to elicit 0 to maximal eIPSP. C, Example of depolarizing eIPSPs (left, blue) and hyperpolarizing eIPSPs (right, red) in response to the contralateral stimulation (top, single-pulse; bottom, 100 Hz stimulation). D, The contralateral stimulation decreased the number of APs (top, right) compared with baseline (top, left). Bath application of the inhibition blockers gabazine (10 μm) and strychnine (1 μm; bottom, right) eliminated the effect. Stimulus artifacts from contralateral stimulation are truncated for clarity and shown in black. E, The normalized spike probability was sensitive to both hyperpolarizing and depolarizing eIPSPs during increasing contralateral stimulation levels. Normalized spike probability was significantly reduced during mid, high, and max normalized eIPSP amplitude levels, compared with control levels (n = 11, p < 0.001, two-way ANOVA with post hoc Bonferroni test). Normalized spike probability was significantly lower for hyperpolarizing inhibition (n = 3) than depolarizing inhibition (n = 8) at high and max normalized eIPSP amplitudes (†p = 0.002). F, Normalized spike probability plotted against eIPSP amplitude of both polarities. The horizontal dashed line indicates a 50% reduction of APs, and the vertical dashed line at 0 mV separates the hyperpolarizing (negative) and depolarizing (positive) eIPSP amplitudes. Contra Stim, Contralateral stimulation.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    LLDp neurons have diverse cell morphology and are GAD65/67 positive. A, Biocytin-filled LLDp neurons have diverse morphology. Most cells have large somas but exhibit different dendritic branching patterns. B–E, Serial sections (50 µm in thickness) of a Nissl stain through the LLD (from left to right: caudal to rostral). LLDp neurons appear more densely distributed at caudal levels, with the number of cells becoming sparser in rostral sections. A magnified view of an oligodendrocyte (arrow) is shown in the inset (C). F–I, Serial sections of a GAD65/67 stain through the LLD (left to right: caudal to rostral). Corresponding magnified view is shown below, highlighting the punctate staining of GAD-positive terminals (f–i). GAD65/67 staining highlights the segregation of the anterior and posterior LLDs, with denser staining on the posterior portion associated with ILD-coding neurons in chicken. At rostral levels, dorsal cells exhibit weaker GAD staining than ventral cells (I). d, dorsal; m, medial.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Avian ILD circuit and theoretical models for ILD coding in LLDp. A. LLDp neurons receive excitatory input from the contralateral cochlear NA and inhibitory input from the contralateral LLDp, and may also receive inhibitory input from the SON, which is driven by excitatory inputs from the ipsilateral NA. LLDp neurons predominantly send inhibitory projections contralaterally to the mesencephalicus lateralis, pars dorsalis (MLd), the auditory midbrain (Wild et al., 2010). B–D, Models of the origin of reciprocal inhibition for ILD coding in the LLDp. The reciprocal inhibition could arise from a single cell type that both encodes ILD and inhibits the contralateral LLDp (B); two cell types, one of which encodes the ILD (black circle) and another cell type that is specialized for fast synaptic transmission and provides the reciprocal inhibition (red triangles; C); or local interneurons that convert excitation into inhibition (D). In all three hypothetical circuits, a dorsal–ventral gradient of inhibition, but not excitation, could provide a topographic readout of ILD to create a space map of sound location in the MLd. Hypothetical schematics of the timing of synaptic inputs (middle column) for EPSPs (blue) and IPSPs (red) show the timing and amplitude for each model when ipsilateral sounds are louder (a) and when contralateral sounds are louder (b). Hypothetical ILD curves (right column) based on the respective model circuit and relative timing of excitation and inhibition. The model in panel C (two cell types) may offer a full-range dynamic coding of ILD (for details, see Discussion). VIII n., 8th nerve; contra, contralateral; ipsi, ipsilateral.

Back to top

In this issue

eneuro: 3 (6)
eNeuro
Vol. 3, Issue 6
November/December 2016
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Synaptic Inhibition in Avian Interaural Level Difference Sound Localizing Neurons
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Synaptic Inhibition in Avian Interaural Level Difference Sound Localizing Neurons
Rebecca J. Curry, Yong Lu
eNeuro 9 December 2016, 3 (6) ENEURO.0309-16.2016; DOI: 10.1523/ENEURO.0309-16.2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Synaptic Inhibition in Avian Interaural Level Difference Sound Localizing Neurons
Rebecca J. Curry, Yong Lu
eNeuro 9 December 2016, 3 (6) ENEURO.0309-16.2016; DOI: 10.1523/ENEURO.0309-16.2016
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • dorsal nucleus of the lateral lemniscus
  • GABAA receptor
  • interaural level difference
  • reversal potential
  • synaptic inhibition

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • Allopregnanolone effects on inhibition in hippocampal parvalbumin interneurons
  • LINCs are vulnerable to epileptic insult and fail to provide seizure control via on-demand activation
  • Pregabalin silences oxaliplatin-activated sensory neurons to relieve cold allodynia
Show more New Research

Sensory and Motor Systems

  • Pregabalin silences oxaliplatin-activated sensory neurons to relieve cold allodynia
  • Supramodal representation of the sense of body ownership in the human parieto-premotor and extrastriate cortices
  • Nonspiking Interneurons in the Drosophila Antennal Lobe Exhibit Spatially Restricted Activity
Show more Sensory and Motor Systems

Subjects

  • Sensory and Motor Systems

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.